Please rate this video

Myeloma 2015 | Advances in monoclonal antibody therapy for multiple myeloma

Please rate this video

Joseph Mikhael

At the Myeloma 2015 meeting, Dr Joseph Mikhael (Mayo Clinic, Scottsdale, AZ) discusses the development of monoclonal antibodies (mAbs), including anti-CD38 mAbs, SAR650984 and daratumumab, and anti-SLAMF7 mAb, elotuzumab, for the treatment of multiple myeloma. Clinical results to date suggest these monoclonal antibodies are likely to operate synergistically with other therapies.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter